43 results
8-K
EX-99.1
MNKD
Mannkind Corp
8 May 24
Results of Operations and Financial Condition
4:05pm
this innovative product to patients more quickly.”
Revenue Highlights
Three Months
Ended March 31,
$ Change
% Change
(Dollars in thousands)
Royalties … for 14 days.
About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic
8-K
EX-99.1
r19v u2eqxsqjce5
8 Nov 22
Mannkind Corporation Reports 2022 Third Quarter Financial Results
8:04am
8-K
EX-99.1
6j6w4mcxpwf
9 Aug 22
Mannkind Corporation Reports 2022 Second Quarter Financial Results
12:00am
8-K
EX-99.1
yd9t5jh7vusa
25 May 22
Other Events
4:06pm
424B5
glvm qsyjfak48jrlj
7 May 19
Prospectus supplement for primary offering
8:31am
424B5
33npbzvfgui1il0yp
21 Dec 18
Prospectus supplement for primary offering
12:00am